Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study
暂无分享,去创建一个
J. Stringer | M. Egger | T. Hallett | R. Wood | G. Wandeler | O. Keiser | M. Davies | A. Boulle | L. Johnson | J. Estill | D. Garone | T. Gsponer
[1] A. Wagstaff,et al. A Cluster Randomized Trial , 2014 .
[2] Kara Wools-Kaloustian,et al. Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. , 2012, International journal of epidemiology.
[3] Thomas Gsponer,et al. Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis , 2012, AIDS.
[4] Richard Degerman,et al. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial , 2011, BMJ : British Medical Journal.
[5] E. Delaporte,et al. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. , 2011, The Lancet. Infectious diseases.
[6] B. Chi,et al. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa , 2011, AIDS.
[7] T. F. Rinke de Wit,et al. Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa , 2011, Journal of acquired immune deficiency syndromes.
[8] M. Egger,et al. Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa , 2011, PLoS medicine.
[9] HIV treatment reaching 6.6 million people, but majority still in need: WHO embarks on a new HIV strategy to boost further progress in 2011-2015. , 2011, Central European Journal of Public Health.
[10] M. Weinstein,et al. Laboratory Monitoring to Guide Switching Antiretroviral Therapy in Resource-Limited Settings: Clinical Benefits and Cost-Effectiveness , 2010, Journal of acquired immune deficiency syndromes.
[11] I. Sanne,et al. Using vital registration data to update mortality among patients lost to follow‐up from ART programmes: evidence from the Themba Lethu Clinic, South Africa , 2010, Tropical medicine & international health : TM & IH.
[12] B. Chi,et al. A Cluster Randomized Trial of Routine HIV-1 Viral Load Monitoring in Zambia: Study Design, Implementation, and Baseline Cohort Characteristics , 2010, PloS one.
[13] A. Wensing,et al. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. , 2010, The Lancet. Infectious diseases.
[14] N. Ford,et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa , 2010, AIDS.
[15] J. Nachega,et al. Evaluation of Paradoxical TB-Associated IRIS With the Use of Standardized Case Definitions For Resource-Limited Settings , 2010, Journal of the International Association of Physicians in AIDS Care.
[16] M. Egger,et al. Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy , 2009, Tropical medicine & international health : TM & IH.
[17] M. Egger,et al. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring , 2009, AIDS.
[18] J. Hogan,et al. Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] M. Egger,et al. Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis , 2009, PloS one.
[20] M. Peeters,et al. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] A. Jahn,et al. Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi , 2009, Tropical doctor.
[22] Organización Mundial de la Salud,et al. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009 , 2009 .
[23] Mark J van der Laan,et al. Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification , 2008, AIDS.
[24] P. Mee,et al. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa , 2008, AIDS.
[25] M. Egger,et al. Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared , 2008, PLoS medicine.
[26] Deenan Pillay,et al. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model , 2008, The Lancet.
[27] Summary TOWARDS UNIVERSAL ACCESS : Scaling up Priority HIV / AIDS Interventions in the Health Sector Progress Report , 2008 .
[28] F. Maggiolo,et al. Effect of Adherence to HAART on Virologic Outcome and on the Selection of Resistance-Conferring Mutations in NNRTI- or PI-Treated Patients , 2007, HIV clinical trials.
[29] S. Lawn,et al. Conservation of First-Line Antiretroviral Treatment Regimen where Therapeutic Options are Limited , 2007, Antiviral therapy.
[30] B. Chi,et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. , 2006, JAMA.
[31] B. Stilwell,et al. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. , 2006 .
[32] L. Myer,et al. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design , 2005, AIDS.
[33] S. Hammer,et al. Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. , 2000, Archives of internal medicine.